Summit Healthcare Acquisition Corp. Warrant
SMIHW
SMIHW was delisted on the 16th of March, 2023.
19 hedge funds and large institutions have $17.1M invested in Summit Healthcare Acquisition Corp. Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
12% less capital invested
Capital invested by funds: $19.4M → $17.1M (-$2.29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DACS
Dymon Asia Capital (Singapore)
Singapore
|
+$72K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$17K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$5.15K |
| 4 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
+$48 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$972K |
| 2 |
UFM
Ursa Fund Management
Danville,
California
|
-$33K |
SMIHW Hedge Fund Activity: Q1 2022 in Review
19 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Summit Healthcare Acquisition Corp. Warrant (SMIHW) for Q1 2022, worth a combined $17.1M — down 12% from $19.4M a quarter earlier.
Fund positioning in SMIHW was balanced in Q1 2022: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Dymon Asia Capital (Singapore), opening a new position worth an estimated $72K. The largest seller was Mangrove Partners, exiting entirely with an estimated $972K sold.
- 19 institutional investors held Summit Healthcare Acquisition Corp. Warrant (SMIHW) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $17.1M of Summit Healthcare Acquisition Corp. Warrant stock for Q1 2022, down 12% quarter-over-quarter.
- 2 funds opened new Summit Healthcare Acquisition Corp. Warrant positions in Q1 2022 and 2 closed out, a net change of 0 holders.
- The largest Summit Healthcare Acquisition Corp. Warrant buyer in Q1 2022 was Dymon Asia Capital (Singapore), an estimated $72K added.
- The largest Summit Healthcare Acquisition Corp. Warrant seller in Q1 2022 was Mangrove Partners, an estimated $972K sold.
Based on aggregated 13F filings for Q1 2022.